Posters

      Systems Toxicology Approach For The Biological Impact Assessment Of Conventional Cigarette Smoke Fractions And Aerosol Fractions From A Prototypic Modified Risk Tobacco Product On Normal Human Bronchial Epithelial Cells

      Kogel, U.; Xiang, Y.; Dossin, E.; Guy, P.; Mathis, C.; Gonzalez-Suarez, I.; Vuillaume, G.; Hayes, A. W.; Hoeng, J.; Peitsch, M. C.

      Conference date
      Mar 23, 2014
      Conference name
      Society of Toxicology (SOT) 2014
      Link to more information
      Topic
      Summary

      Smoking causes serious fatal diseases such as lung cancer and chronic obstructive pulmonary disease. Bronchial epithelial cells as the first barrier against invading organisms and exposure to chemicals play a major role in the pathogenesis of these diseases. In order to demonstrate the applicability of a Systems Toxicology Approach to evaluate the risk associated with prototypic Modified Risk Tobacco Products (pMRTPs), normal Human Bronchial Epithelial (nHBE) cells were exposed to an aqueous cigarette smoke fraction (smoke bubbled into phosphate-buffered saline/sbPBS) from the 3R4F reference cigarette at three non-toxic doses based on cell viability for either 4 or 24 hours. The pMRTP aerosol doses in sbPBS were matched to the highest concentrations of 3R4F in terms of puff/ml. A static headspace GC/MS method focusing on volatile and semi-volatile constituents revealed that most of the levels of the 85 monitored constituents were lower in sbPBS of the pMRTP as compared to the 3R4F. Whole genome transcriptomics analysis of nHBE cells demonstrated a dose-dependent increase in the number of differentially expressed genes for the 3R4F sbPBS exposure. Fewer genes were differentially expressed after exposure to sbPBS from the pMRTP. Analysis using computable biological network models showed the perturbation of biological processes related to cell stress and senescence after 4 hours of exposure to sbPBS from 3R4F, whereas after 24 hours of exposure the cell proliferation network was most perturbed. Exposure to the pMRTP resulted in much attenuated perturbation of biological networks. In summary, we provide mechanistic insight of the biological impact on key cellular processes in nHBE cells upon sbPBS exposure, suggesting reduced biological network perturbation from exposure to pMRTP compared to 3R4F.

      Related Publications

      Indoor Air Chemistry - An exploratory study on e-cigarette shows no negative impact on indoor air quality

      Aerosol Chemistry

      Indoor air chemistry - An exploratory study on e-cigarette shows no negative impact on indoor air quality

      Aerosol Chemistry

      Computer-Assisted Structure Identification (CASI) for high-throughput identification of small molecules using GC×GC-HRAM-TOFMS high-resolution accurate mass spectrometry

      Aerosol Chemistry

      Computer-Assisted Structure Identification (CASI) for high-throughput identification of small molecules using GC×GC-HRAM-TOFMS high-resolution accurate mass spectrometry

      Aerosol Chemistry

      Air quality assessment during indoor use of the Tobacco Heating System 2.2

      Aerosol Chemistry

      Air quality assessment during indoor use of the Tobacco Heating System THS 2.2

      Aerosol Chemistry

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.